2017
DOI: 10.1080/15265161.2017.1328899
|View full text |Cite
|
Sign up to set email alerts
|

Modernizing Research Regulations Is Not Enough: It's Time to Think Outside the Regulatory Box

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
15
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 10 publications
(15 citation statements)
references
References 0 publications
0
15
0
Order By: Relevance
“…Such data usage, however, deviates from the ambit of current standards for safeguarding participants and nonparticipants against violations of integrity, such as standard informed consent and anonymization procedures, and methods of protecting data ( Barocas & Nissenbaum, 2014 ; boyd & Crawford, 2012 ; Keymolen, 2016 ; Mittelstadt & Floridi, 2016 ; Robinson et al, 2013 ). Moreover, it raises questions regarding the confidentiality of personal data, possible stigmatization, and uncertainty about who has access to the data ( boyd & Crawford, 2012 ; Gibson et al, 2017 ; Graeff & Harmon, 2002 ; Mittelstadt & Floridi, 2016 ; Rivera et al, 2017 ). Health and medical care will be prioritized in relation to science and innovation over the next 15 years ( Eurobarometer, 2014 ).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Such data usage, however, deviates from the ambit of current standards for safeguarding participants and nonparticipants against violations of integrity, such as standard informed consent and anonymization procedures, and methods of protecting data ( Barocas & Nissenbaum, 2014 ; boyd & Crawford, 2012 ; Keymolen, 2016 ; Mittelstadt & Floridi, 2016 ; Robinson et al, 2013 ). Moreover, it raises questions regarding the confidentiality of personal data, possible stigmatization, and uncertainty about who has access to the data ( boyd & Crawford, 2012 ; Gibson et al, 2017 ; Graeff & Harmon, 2002 ; Mittelstadt & Floridi, 2016 ; Rivera et al, 2017 ). Health and medical care will be prioritized in relation to science and innovation over the next 15 years ( Eurobarometer, 2014 ).…”
mentioning
confidence: 99%
“…Centralized information storage in biobanks inevitably poses a threat to participants’ privacy. The decision to participate in a biobank entails accepting unknown short-term and long-term privacy risks concerning the confidentiality of personal data, the use of such data for unintended research purposes, or possible stigmatization ( boyd & Crawford, 2012 ; Gibson et al, 2017 ; Graeff & Harmon, 2002 ; Mittelstadt & Floridi, 2016 ; Nobile et al, 2016 ; Rivera et al, 2017 ). This situation results in a social dilemma in which the collective interest of promoting the public good and the individual interest of keeping data or information private are opposed.…”
mentioning
confidence: 99%
“…The adoption of a more personalized approach in relation to potential participants could be facilitated through the development of new models for communicating information and recruiting participants for health research [60,61]. A limited focus on facts and consent within the prevailing generalized information and communication procedures leads to the oversimpli cation of researcher-participant interactions [8,58] that does not address the need for more layered and informative interactions in the contemporary context of data collection and research. Our ndings revealed that issues of individual or societal bene ts and risks importantly in uenced the respective decisions of ex-participants and non-participants to withdraw or not to participate at all.…”
Section: Discussionmentioning
confidence: 99%
“…They constitute valuable resources for healthcare professionals and facilitate innovations in epidemiological, genetic, and public health research [2,4]. These data repositories facilitate the e cient performance of large-scale and continuous data analyses and enable researchers and clinicians to generate individual tailored clinical care [5][6][7][8][9]. Contributing personal data to biomedical research must be voluntary [9][10][11][12][13][14].…”
Section: Introductionmentioning
confidence: 99%
“…The proposals that were disseminated over the course of this recent modernization effort proved to be remarkably controversial and ultimately resulted in a final rule that was widely considered to represent only a minor update to the original regulations. 7 Given this recent history, there is little energy in the regulatory and health policy community to start this process anew. If it were necessary to revise the Common Rule to allow for the change in practice that Berkman et al 1 propose, it is unlikely that such a revision will be seriously considered in the next decade.…”
Section: Kyle B Brothers Commentsmentioning
confidence: 99%